 Lantern Pharma NASDAQ: LTRN, a clinical stage biotechnology company using its proprietary RADR artificial intelligence A.I. platform to improve drug discovery and development and, identify patients who will benefit from its portfolio of targeted oncology therapeutics, announced today that it will host a conference call and live webcast on Thursday, July 30, 2020 at 8:00 a.m. Eastern Time to discuss financial and operating results for the second quarter ended June 30, 2020. 